Fluoxetine Therapy in Obese Diabetic and Glucose Intolerant Patients

Kutnowski, M.;Daubresse, JC.;Friedman, H.;Kolanowski, Jaroslaw;Vangaal, L.;et.al.
(1992) International Journal of Obesity — Vol. 16, p. S63-S66 (1992)

Files

No attached file found for this publication.

Details

Authors
  • Kutnowski, M.
    Author
  • Daubresse, JC.
    Author
  • Friedman, H.
    Author
  • Author
  • Vangaal, L.
    Author
Show more
Abstract
A double-blind placebo-controlled trial was conducted, involving 97 obese diabetic and glucose intolerant patients receiving either 60 mg fluoxetine daily (47 patients) or a placebo (50 patients); a similar calorie-restricted diet was prescribed to all patients. Weight loss was significantly higher in the fluoxetine-treated patients, whose diabetic status improved. Drop-out rate was not significantly different for both groups of patients.
Affiliations

Citations

Kutnowski, M., Daubresse, JC., Friedman, H., Kolanowski, J., Krzentowski, G., Scheen, A., & Vangaal, L. (1992). Fluoxetine Therapy in Obese Diabetic and Glucose Intolerant Patients. International Journal of Obesity, 16, S63-S66. https://hdl.handle.net/2078.5/42382 (Original work published 1992)